0001104659-23-095361.txt : 20230825 0001104659-23-095361.hdr.sgml : 20230825 20230825163129 ACCESSION NUMBER: 0001104659-23-095361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dietz Thomas John CENTRAL INDEX KEY: 0001574218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37990 FILM NUMBER: 231208823 MAIL ADDRESS: STREET 1: C/O TRANSCEPT PHARMACEUTICAL, INC. STREET 2: 1003 W. CUTTING BLVD, STE 110 CITY: PT. RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274412575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 252 4343 MAIL ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Dekkun Corp DATE OF NAME CHANGE: 20110107 4 1 tm2324823-7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-23 0 0001509745 LEAP THERAPEUTICS, INC. LPTX 0001574218 Dietz Thomas John C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02141 1 0 0 0 0 Stock Option (Right to Buy) 2.21 2023-08-23 4 A 0 17500 0 A 2033-08-23 Common Stock 17500 17500 D The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. /s/ Douglas E. Onsi as attorney-in-fact for Thomas Dietz 2023-08-25